post-transcriptional modification of rna is an important determinant of rna quality control, translational efficiency, rna-protein interactions and stress response. this is illustrated by the observation of toxicant-specific changes in the spectrum of trna modifications in a stress-response mechanism involving selective translation of codon-biased mrna for crucial proteins. to facilitate systems-level studies of rna modifications, we developed a liquid chromatography-mass spectrometry (lc-Ms) technique for the quantitative analysis of modified ribonucleosides in trna. the protocol includes trna purification by Hplc, enzymatic hydrolysis, reversed-phase Hplc resolution of the ribonucleosides, and identification and quantification of individual ribonucleosides by lc-Ms via dynamic multiple reaction monitoring (DMrM). In this approach, the relative proportions of modified ribonucleosides are quantified in several micrograms of trna in a 15-min lc-Ms run. this protocol can be modified to analyze other types of rna by modifying the steps for rna purification as appropriate. By comparison, traditional methods for detecting modified ribonucleosides are labor-and time-intensive, they require larger rna quantities, they are modification-specific or require radioactive labeling.
IntroDuctIon
Most forms of RNA in prokaryotic and eukaryotic cells contain modified ribonucleosides in addition to the canonical adenosines, guanosines, cytidines and uridines, with more than 100 different chemical structures across all organisms and 2-3 dozen in any one organism (structures of several modified ribonucleosides in tRNA from Saccharomyces cerevisiae are shown, for example, in Fig. 1 ) [1] [2] [3] [4] [5] [6] . tRNA is the most heavily modified RNA species, with the presence of specific ribonucleoside structures affecting the rate and fidelity of translation [3] [4] [5] [6] , tRNA stability 7, 8 , cellular stress responses [9] [10] [11] and cell growth 12 . However, emerging evidence points to a systems-level function of the complete set of modified ribonucleosides. For example, several recent studies have revealed a role for tRNA modifications in controlling cellular stress response and phenotype by directing the selective, codonbiased translation of specific mRNAs 10, 13, 14 , with unique changes in the levels of modified ribonucleosides for different stimuli and stresses 10, 14, 15 .
The discovery of this emergent property of tRNA modifications has been enabled in part by application of LC-MS to quantify the complete set of tRNA modifications and how its composition varies in response to different stresses. Traditional approaches to quantifying individual modified ribonucleosides, such as 2D thin-layer chromatography 16, 17 , are semiquantitative at best, and they are not suitable for studying all tRNA modifications at once, in addition to being labor-and time-intensive and involving radioactive labeling. MS-based methods have recently emerged as powerful tools for identifying and quantifying RNA modifications [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . For example, we recently developed a rigorously quantitative platform for LC-MS analysis of the system of modified ribonucleosides in the population of tRNA molecules in a cell or in individual, purified tRNA species (Fig. 2) , with the method applied to studies in bacteria, yeast and human cells 14, 15, [28] [29] [30] .
Application of this approach to the identification and quantification of 25 tRNA ribonucleoside modifications in S. cerevisiae led to the discovery of a direct link between cell stress and translation of stress-response proteins 14, 15 . As illustrated in Figure 2 , the basic approach involves five stages: (i) tRNA purification and quantification; (ii) hydrolysis of tRNA to individual ribonucleosides; (iii) reversed-phase HPLC resolution of ribonucleosides; (iv) identification and quantification of ribonucleosides by tandem quadrupole mass spectrometry (QQQ); and (v) multivariate statistical analysis of patterns of change in the set of modified ribonucleosides caused by the stress or stimulus.
By using this approach as an exploratory tool, we discovered that yeast respond to different chemical stresses with agentspecific changes in the relative quantities of the two dozen modified ribonucleosides in tRNA, or 'reprogramming of the tRNA modifications', which leads to selective translation of codon-biased mRNAs representing proteins that are crucial for the stress response to the specific chemical stressor 10, 14, 15, 30 . Here we present a protocol for the LC-MS platform for quantitative analysis of modified ribonucleosides in total tRNA isolated from a cell. The data are used to assess population-level changes in the relative quantities of the ribonucleosides regardless of whether the changes occur by alterations in tRNA copy number, in the activity of tRNA-modifying enzymes or both. The patterns revealed by this approach provide clues for subsequent analysis of individual tRNA species and tRNA copy numbers.
One key advantage of the LC-MS protocol described herein with respect to alternative methods is the highly quantitative nature of the approach. This characteristic is crucial, as it enables researchers to identify not only the presence or absence of certain modifications in mutants lacking modification pathways, but, more importantly, to quantify changes in modification Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry levels that result from altered regulatory pathways in cells, a task that is very difficult to perform using traditional methods. For example, with the present protocol, we found that oxidative stress caused an increase in the level of 5-methylcytidine (m 5 C) and a reduction in the level of 5-methoxycarbonylmethyl-2-thiouridine (mcm 5 s 2 U) in total tRNA 1 h after exposing yeast to hydrogen peroxide 14, 15 (Fig. 3, structures in Fig. 1 ). Having identified ribonucleosides for which stress-induced changes are substantial, we then used established approaches, such as RNase-based mass spectrometric mapping of modified ribonucleosides in specific tRNAs 19 , to quantify changes in the level of m 5 C at the wobble position of tRNA LeuCAA that led to selective translation of genes enriched in TTG codons 14 . Although the in vivo kinetics of tRNA modification have not been measured, the observation of changes in the levels of tRNA modifications within 1 h of cell exposure points to a regulatory system involving increased enzyme activity and/or increased tRNA copy numbers, or degradation of tRNA species [7] [8] [9] 31, 32 and possible enzymatic removal of modifications. For instance, oxidative demethylation, which is known to occur in DNA with 5-methyl-2′-deoxycytidine 33 , may also take place in tRNA, as suggested by the presence of demethylation motifs in tRNA-modifying enzymes such as ABH8 (refs. 34-36) .
An important feature of this quantitative approach is that it can be applied to any type of coding and noncoding RNA, when coupled with an appropriate RNA purification technique. The implementation of such a technique is especially important in light of the presence of modified ribonucleosides in virtually every form of coding and noncoding RNA in all living organisms [37] [38] [39] [40] [41] [42] . A key requirement of the present approach is the isolation of specific RNA species free from contamination of other RNA species or RNA fragments, so as to avoid the wrongful identification of modifications that do not exist in the species of interest. A variety of chromatographic and nonchromatographic methods exist for purifying noncoding RNA species [43] [44] [45] [46] [47] [48] [49] [50] [51] , including our recently developed multidimensional HPLC method 52 , with polyA affinity purification methods for mRNA species. Here we used the HPLC approach for tRNA purification; the procedure could be adapted to the analysis of other RNA species by replacing the steps relating to the purification of tRNA with steps specific to other RNA species.
Experimental design
Several crucial features of the experimental design are beyond the scope of the protocol detailed below, yet they have a crucial role in the outcome of the experiments. The first is the quality and accurate quantification of the purified RNA subjected to LC-MS. Most commercial kits do not provide the purity of tRNA or other RNA molecules necessary for truly precise and accurate quantification of modified ribonucleosides in the RNA species of interest. For example, small RNA isolation kits yield RNA species up to ~200 nt, with tRNA representing 80-95% of the purified tRNA 15 and with potential contamination with 5S and 5.8S rRNA, rRNA degradation products and microRNA species. Further purification of tRNA by chromatographic methods 52 or acrylamide gel electrophoresis 14 reduces the risk of contamination problems. We have successfully used both approaches, with HPLC purification used in this procedure 10, 14, 15, 30 . Furthermore, different RNA isolation methods have been shown to bias the isolation toward large or small RNA species and to different sequence enrichments in the RNA [53] [54] [55] . The isolation and purification method could also lead to artifacts caused by oxidation or enzymatic deamination, such as those known to occur in DNA, which can be reduced by incorporation of antioxidants and deaminase inhibitors 56 . For example, care must be taken to avoid enzymatic deamination of adenosine to inosine by deaminases that contaminate some preparations of alkaline phosphatase 56, 57 , and to avoid loss of redox-sensitive modifications, such as the loss of 5-hydroxycytidine observed in prokaryote rRNA 58 . Finally, precise and accurate quantification requires both biological and technical replicates of the analyses. In general, experiments should be performed with technical duplicate analyses of each of three biological replicates for each condition, along with untreated cells. Another important prerequisite to the analysis of stress-induced reprogramming of tRNA modifications is the identification of the complete set of modified ribonucleosides in an organism. The current databases are focused on individual modifications discovered over decades of study, mainly for Escherichia coli, yeast and human cells 2, 22 . This means that most modified ribonucleosides are known for these organisms, but for few other organisms. Even with ~70% conservation of the various structures across all organisms, there is still the need to identify the HPLC elution behavior of the modified ribonucleosides from well-studied organisms, which requires the use of commercial standards (see MATERIALS) or the identification of ribonucleosides by high-mass-accuracy MS, collision-induced dissociation (CID) MS and NMR spectroscopy.
Finally, there is the issue of instrument setup. We have used Agilent UPLC-coupled MS systems, and the methods we describe here can be readily translated to LC-MS systems from other manufacturers. The parameters in need of attention are settings of the source (ionization energy, temperature, gas flow, etc.), the analyzer (collision energy, gas flow, etc.) and the detector (mode of detection, exact monitored mass transitions, etc.). We used the DMRM program available on the Agilent instrument to achieve higher sensitivity, and similar programs are available for other modern QQQ instruments. For example, AB Sciex QQQ instruments have a feature called 'scheduled multiple reaction monitoring (MRM),' whereas Thermo Fisher QQQ instruments have 'timed selected reaction monitoring (SRM)' . These software programs all work in a similar fashion to optimize the sensitivity of detecting individual ribonucleosides with known structure and mass. For older instruments that lack such programs, MRM can be set up to achieve the same goal, although with reduced sensitivity.
Perhaps the most crucial stage in this LC-MS platform for quantitative comparison of changes in modified ribonucleosides across samples is the quantification of RNA in each sample. Standard spectroscopic methods (i.e., measurement of A 260 values) are entirely inadequate for this purpose, as they are heavily affected by contamination with even small amounts of protein, DNA, buffers and other chemicals. However, even highly precise and accurate RNA quantification methods, such as fluorescent dye binding 52 , will not provide accurate information about the RNA content of the sample if the method is applied too early in the sample processing. Notably, loss of RNA in subsequent HPLC purification and enzymatic digestion steps will cause artifacts in RNA quantification and wide variations in data from replicate samples. The optimal solution to these issues is to quantify the canonical ribonucleosides (i.e., cytidine, uridine, adenosine and guanosine) in the fully processed sample at the time of LC-MS analysis, which can be achieved by using an in-line UV absorbance detector with an external calibration curve. Alternatively, one can quantify the canonical ribonucleosides by MS in a second run on the instrument with a dilution of a small portion of the original sample when the in-line UV absorbance detector is not available. Either approach will provide the most accurate measurement of input RNA concentration by which to normalize the MS signals for the individual modified ribonucleosides in comparisons across different samples, which obviates problems with protein and DNA contamination. Here we used the in-line UV diode array detector module coupled to an Agilent 1290 UPLC instrument to quantify the canonical ribonucleosides. To avoid problems caused by day-to-day variation in instrument performance, the precision of relative quantification of modifications across different analysis sessions may be enhanced by spiking into the fully processed analyte an internal standard, such as [ 15 N] 5 -2-deoxyadenosine ([ 15 N]-dA), to a final concentration of 40 nM immediately before MS analysis. If all samples are analyzed on the same day, this internal standard approach is not necessary 14, 15 . Absolute quantification of individual modified ribonucleosides can be achieved by preparing external calibration curves with a synthetic standard of the ribonucleoside. However, this is beyond the scope of this protocol.
Limitations
As with all methods, there are limitations to this LC-MS platform, and many of them have already been discussed. Other limitations include the level of sensitivity of the LC-MS protocol, which, even with optimized RNA isolation and analytical parameters, can result in the inability to detect and quantify rare modified ribonucleosides. For example, of the 25 tRNA modifications known to be present in yeast, we were not able to detect 2′-O-ribosyladenosine phosphate (Ar(p)) in positiveion mode, possibly owing to the strong negative charge of the phosphate, and we made only tentative identification of 5-carbamoylmethyl-2′-O-methyluridine (ncm 5 Um) by CID owing to weak signal intensities 15 .
In spite of the few limitations of the method, the following LC-MS platform provides highly precise quantification of changes in the spectrum of modified ribonucleosides in tRNA from any organism, facilitating the study of translational control of cellular responses and phenotypes. EQUIPMENT SETUP HPLC setup For HPLC setup (operating parameters, solvent parameters and so on), follow the manufacturers' instructions for instrument operation, with particular attention paid to the parameters specific to the experiments performed in this protocol. HPLC column equilibration for the size-exclusion step for tRNA purification and the reversed-phase resolution of ribonucleosides is described in specific sections in this protocol, and parameters for experiments described in this protocol are shown in the 
Mass spectrometer parameters Value
Gas temperature (°C) 350
Gas flow (liters/min) 10
Nebulizer gas (p.s.i.) 20
Capillary voltage (V) 3,500
Delta electron multiplier voltage (V) 650 All ions were detected in positive ion mode. Cell acceleration voltage was set to 7 for all transitions. a The full name for each ribonucleoside is noted in Figure 5 . 4| Add 25 ml of TRIReagent to the cell lysate, vortex it and allow it to stand at ambient temperature for 5 min.
5| Add 5 ml of chloroform to the mix and allow it to stand at ambient temperature for 3 min.
6|
Centrifuge the sample at 12,000g for 15 min at 4 °C.
7|
Transfer the aqueous phase to a new tube.
8|
To the aqueous phase, add 0.5 ml of 100% isopropanol per ml of TRIReagent used for homogenization.
9| Incubate the tube from
Step 8 at ambient temperature for 10 min.
10|
Centrifuge the mixture at 12,000g for 10 min at 4 °C.
11|
Remove the supernatant to leave an RNA pellet.
12| Wash the pellet with 1 ml of 75% (vol/vol) ethanol in water per ml of TRIReagent used in the initial homogenization. Vortex the sample briefly, and then centrifuge the tube at 7,500g for 5 min at 4 °C. Discard the supernatant washing solution.
13| Repeat
Step 12 once more.
14| Air-dry the RNA pellet for 5-10 min.
15|
Resuspend the RNA pellet in RNase-free water and measure the RNA concentration by measuring the A 260 value or by other means. Generally, ~100 µg of total RNA can be extracted from 100 ml of yeast culture.
? trouBlesHootInG 16| Check the quality of the isolated total RNA by running a fraction on a Bioanalyzer, or by performing gel electrophoresis. See the example of an Agilent Bioanalyzer output for total RNA from human cells in Figure 4 . Visual analysis of the gel or image will reveal gross degradation, with loss of the individual peaks for tRNA and rRNAs. More subtle degradation can be detected using the RNA Integrity Number (RIN), which is an index of RNA quality based on the 28S/18S ratio, and is calculated by the Agilent Bioanalyzer software (see http://www.genomics.agilent.com/article.jsp?pageId=2181). Low-quality RNA could be due either to sample handling, which necessitates repeating the experiment, or to the cellular stress response, which indicates the need to use lower levels of stimulant or toxicant exposure.
? trouBlesHootInG 17| Prepare 10-50-µl aliquots and store total RNA at − 80 °C until further use.  pause poInt The purified RNA can be stored at − 80 °C for at least 3 months.
Isolation of total trna from total rna by Hplc • tIMInG 2-3 h 18|
Completely thaw an aliquot of total RNA on ice and immediately proceed to the next step.
19| Denature the RNA sample by incubating it on a heating block at 70 °C for 2 min, and then place it on ice for at least 5 min.  crItIcal step Failure to heat-denature RNA before loading the solution to the HPLC device can result in very wide peaks and little separation.
20|
Measure the RNA concentration by absorbance at 260 and 320 nm. The absorbance at 260 nm should be corrected by subtracting absorbance at 320 nm, which is used as the background of the measured spectrum. Measured with a 1-cm path length, 1 absorbance unit at 260 nm (A 260 unit) is roughly equivalent to 40 µg/ml of RNA.
21|
If the RNA concentration is < 5 mg/ml, concentrate total RNA on a Microcon YM-10 centrifugal filtration cartridge according to the manufacturer's instructions, or by using a similar system.
22|
Transfer 50 µg of total RNA ( < 10 µl volume) into a 100-µl vial insert tube, place the insert in a 2-ml screw-top vial and cap the vial.  crItIcal step After transferring the RNA to the insert tube, check for bubbles at the bottom of the insert tube and use a pipette to dislodge or remove any bubbles, the presence of which would interfere with the HPLC-based purification of the tRNA.
23|
Equilibrate an Agilent SEC-3 300-Å HPLC column (300-mm length × 7.8-mm inner diameter) on Agilent 1100 Series or a similar HPLC system with a temperature-controlled column compartment at 65 °C with 100 mM ammonium acetate aqueous phase at a flow rate of 0.5 ml/min for at least 20 min.
24|
To determine the retention time of the tRNA, inject 1 µl of total RNA into the HPLC according to the directions in Step 22.
25|
Record the retention time and peak width of the tRNA signal. 26| Inject the remaining total RNA solution into the HPLC system and collect the tRNA peak by using the retention times noted in Step 25. Collection of the tRNA can be performed manually or by programming the HPLC with a fraction collector.  crItIcal step Be careful not to overload the HPLC column. The Agilent SEC-3 300-Å HPLC column has a maximal capacity of ~100 µg of RNA.
27|
Mix the volume of collected tRNA with 0.1 volumes of 3 M sodium acetate (pH 5.2), and then add 2.5 volumes of ice-cold 100% ethanol and 20 µg of glycogen. Invert the tube a few times to fully mix the contents.
28|
Place the tube at − 80 °C for at least 20 min.
29|
Centrifuge the tube at 14,000g for 30 min at 4 °C. A white pellet should appear at the bottom of the tube.
30|
Remove the supernatant carefully and add an equal volume of 70% (vol/vol) ethanol in water to the tube. Mix it thoroughly.
31| Centrifuge the tube for at 14,000g for 5 min at 4 °C and again discard the supernatant.
32| Repeat Steps 29 and 30.
33| Air-dry the precipitated tRNA for 5-10 min at ambient temperature.
34|
Dissolve the dried tRNA in 20 µl of RNase-free water.
35|
Measure the RNA concentration as in Step 20.
36| Remove 1 µl of total tRNA and dilute it with RNase-free water to a concentration of 50-500 ng/µl.
37|
Analyze the diluted sample with an Agilent Bioanalyzer small RNA chip to determine the integrity and purity of purified total tRNA. The sample should be completely free of microRNA, 5S rRNA and other contaminants. An example of Agilent Bioanalyzer analysis of total RNA and purified total tRNA from human cells is shown in Figure 3 .  pause poInt The purified tRNA can be stored at − 80 °C for at least 3 months.
Hydrolysis of trna to nucleosides and dephosphorylation of nucleosides • tIMInG 4-5 h 38|
Place 10 µg of total tRNA in a microcentrifuge tube on ice.
39| Use the volumes specified in the following table to prepare a mixture containing all of the enzymes and cofactors needed for hydrolysis of the RNA into nucleosides.
stock solutions of reagents Volume added (ml)
Tris-HCl, 500 mM (pH 8.0), 10 mM MgCl 2 , 1 mg/ml BSA 25
Benzonase, 5 U µl − 1 10
Phosphodiesterase I, 0.1 U µl − 1 5
Alkaline phosphatase, 1 U µl − 1 5
RNase-free H 2 O 5
Total volume 50
40| Add 10 µl of the mixture prepared in
Step 39 to each sample of tRNA, and then bring the final volume to 50 µl with RNase-free water.
41|
Incubate the samples at 37 °C for 3 h.
42|
Enzyme removal. Rinse a 10,000-Da MWCO spin filter (Amicon) by adding to it 300 µl of deionized water and centrifuging for 5 min at 16,000g at 4 °C.
43|
Place each rinsed spin filter onto a fresh collection tube.
44|
Transfer the hydrolyzed RNA sample to the rinsed spin filter and centrifuge for 10 min at 16,000g at 4 °C.
45|
Transfer the filtrate from Step 44 to a 100-µl vial insert tube, place it in a 2-ml screw-top vial and cap the vial. These samples will be analyzed in Step 55.  crItIcal step After the RNA has been transferred to the insert tube, check for bubbles at the bottom of the insert tube and use a pipette to dislodge or remove any bubbles.  pause poInt The samples in vials can be stored at − 20 °C for at least 2 weeks and for longer at − 80 °C.
optimization of the mass spectrometer parameters for targeted ribonucleosides • tIMInG 1-2 d 46| By using an appropriate set of the commercial ribonucleoside standards listed in the Reagents section (most are present in all organisms), use a stock solution of each ribonucleoside to prepare a 50-µl solution at a final concentration of ~0.2 ng/µl in a 100-µl vial insert tube inserted into a 2-ml screw-top vial. Cap the vial. Proceed to make multiple injections of the same sample, using different injection volumes from 1 to 10 µl. The ability to detect a roughly linear (nonlinear is acceptable) increase in peak area for each ribonucleoside provides an estimate of the dynamic range for detecting the ribonucleosides.
47|
Connect a column-free UPLC system directly to a QQQ mass spectrometer with 0.1% (vol/vol) formic acid as the solvent, and set up the MassHunter Optimizer program with the parameters listed below. 48| Initiate the MassHunter Optimizer program. The UPLC system autosampler will inject a volume of the sample into the mass spectrometer and determine optimal ionization and fragmentation conditions. Examples of optimized conditions for several ribonucleosides are listed in table 1. These values will be used in Step 52 to set up the DMRM table.  crItIcal step These conditions will vary substantially for different instruments and for different versions of the same instrument, so the conditions should be determined at least once for the user's specific instrument.
? trouBlesHootInG
49|
Determination of retention times of the modified ribonucleosides. Connect a Hypersil GOLD aQ 3-µm column (150-mm length × 2.1-mm inner diameter, pore size 120 Å, particle size 3 µm; the UPLC version with a 1.9-µm particle size also works well, but other chromatographic parameters will differ) to the QQQ mass spectrometer system and equilibrate the column to 36 °C with 0.1% formic acid in HPLC-grade water at a flow rate of 0.4 ml/min for at least 20 min.
50| Dilute stocks of standard ribonucleosides in RNase-free water to give 0.1-1 ng/µl solutions, transfer each sample to a 100-µl vial insert, place the insert tube into a 2-ml screw-top vial and cap each vial.
51|
Inject the ribonucleoside standard into the LC-MS system, and note the retention time according to the solvent gradient described in the following 
53|
Equilibrate the UPLC-coupled QQQ system as described in Step 49.
54|
Create a work list in the MassHunter acquisition software, including the sample positions in the autosampler, the method that was set up in Step 52, and the volume to inject for each sample.
55|
Place the sample vials prepared in Step 45 in the autosampler positions noted in the work list from Step 54.
56|
Run the work list. The total ion chromatogram of a typical run of digested yeast total tRNA is shown in Figure 5 . Note: to prevent large variances in data, it is best to analyze all samples of the same experiment including control samples in the same run.
Data analysis • tIMInG 3-5 h 57|
For each sample run, a sample data file will be generated by the acquisition software. Open this data file with the Agilent Qualitative Analysis software, which is included with Agilent instruments, and get the raw data for each sample. The total ion current chromatogram (TIC) is displayed by default. Right-click on the sample file name and select 'extract chromatogram', and then select MRM to extract all MRM peaks. The software will do an automatic integration of the peaks. The user will then need to manually check all peaks to make sure that the autointegration-generated peaks are correct. If they are not, the user will have to implement a manual integration. Instructions for manual integration can be found in the software help files. 15 .
58|

antIcIpateD results
The protocol described here provides a means to detect marked changes in the relative quantities of tRNA modifications in cells subjected to stimuli and exposed to different agents. Practitioners can anticipate detection and quantification of most modified ribonucleosides in ~0.5-10 µg of tRNA from any source, with m/z and retention time values used to identify those modified ribonucleosides of unknown identity (i.e., molecules shown to possess a ribose or 2′-O-methyl ribose moiety). To demonstrate the power of the method, we examined the tRNA modifications of two S. cerevisiae strains, wild-type and trm9∆, in which the tRNA methyltransferase 9 (TRM9) gene is deleted. Trm9 is required for the formation of 5-methoxycarbonylmethyluridine (mcm 5 U) and mcm 5 s 2 U at wobble positions of certain tRNAs 10, 28 . By using the workflow described here, we analyzed the ribonucleosides of tRNAs from both the wild-type and trm9∆ cells. A comparison of the two sets of data revealed that the relative quantities of most modified ribonucleosides remained unchanged, except for 5-carboxymethyluridine (cm 5 U), mcm 5 U and mcm 5 s 2 U (Fig. 3, structures in Fig. 1 ). As expected, in wild-type yeast, both mcm 5 U and mcm 5 s 2 U are present, whereas cm 5 U is absent, whereas in trm9∆ cells neither mcm 5 U nor mcm 5 s 2 U is present, and cm 5 U accumulates (Fig. 3) . The method is highly precise, with 3.1% intra-day variance in average signal intensity and 12.1% inter-day variance in average fold-change values for each ribonucleoside in tRNA from yeast cells (statistics determined from 294 analyses in three biological replicates over several weeks) 15 . These data point to the importance of reducing variance by performing critical comparative analyses on the same day.
